Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus to everolimus conversion after kidney transplantation
NL-OMON24603Not yet recruiting
- Sponsor
- Erasmus MC
- Start
- Oct 2010
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in Kidney allograft status (RTx) comparing Continue tacrolimus with Convert to everolimus (2 arms). Primary endpoints: Mean MDRD-estimated glomerular filtration rate at month 12 and Change in MDRD-estimated glomerular filtration rate from month 3 to month 12. Planned start Oct 2010; status: not yet recruiting.
02
Drugs
everolimustacrolimus
03
Conditions
Kidney allograft status (RTx)
Beyond the preview
Go deeper on NL-OMON24603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24603.